Tag Archives: ZIOP

Top 5 Performing Stocks To Own For 2018

Bank of America’s (NYSE:BAC) shares suddenly dropped last week, slumping ~6 percent on Tuesday as investors rushed to sell financials and take profits in stocks that have soared since the U.S. election. Republicans also don’t appear to be able to score legislative victories as easily as investors thought, which raises concerns over the sustainability of the Trump rally.

Let’s first agree that Bank of America has been a very good investment already in the last several months, but especially over the last year. Believe it or not, but an investment in Bank of America has returned ~70 percent since March 28, 2016, outperforming other financial stocks as well as major stock market indices by a wide margin.

Top 5 Performing Stocks To Own For 2018: Dave & Buster's Entertainment, Inc.(PLAY)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap restaurant and entertainment stockDave & Busters Entertainment Inc (NASDAQ: PLAY)updated guidance for its fiscal 2017 (which ends on February 4, 2018):

  • [By Stephan Byrd]

    Equities analysts expect Dave & Buster’s (NASDAQ:PLAY) to report $324.81 million in sales for the current fiscal quarter, according to Zacks. Six analysts have issued estimates for Dave & Buster’s’ earnings, with estimates ranging from $320.19 million to $332.00 million. Dave & Buster’s posted sales of $304.15 million during the same quarter last year, which suggests a positive year over year growth rate of 6.8%. The firm is scheduled to report its next quarterly earnings report on Tuesday, June 5th.

  • [By Trey Thoelcke]

    Dave & Buster’s Entertainment Inc.’s (NASDAQ: PLAY) fiscal fourth-quarter report is scheduled for Tuesday after the markets close. The consensus estimates are $0.60 in earnings per share (EPS) on $305.49 million in revenue. The shares ended the week at $41.74. The consensus price target is $65.33, and the 52-week trading range is $41.04 to $73.48.

  • [By Matt Hogan]

    Casual-dining chains have not been winners during this economic expansion. Millenials, with their need for more social media-worthy experiences, have been blamed for the decline in conjunction with Baby Boomers moving onto fixed incomes as they retire.

    Dave & Buster's Entertainment Inc (NASDAQ: PLAY) provides an eat, drink, play, and watch experience for consumers. This hybrid entertainment/dining experience has fared well since going public in 2012, attracting higher-income adults in the 21-39 age range.
    Poor same-store sales last quarter knocked the premium off the stock price, but top and bottom-line growth were still strong. Margins and efficiency ratios top its competitors, and Wall Street and quant valuation models agree that there is a strong upside for this diamond in the casual-dining rough.

    You'll Probably Want to Sit Down for This

    Casual dining, the traditional sit-down, full-service restaurant experience is getting hit by demographics. Millennials want hip, social-media worthy experiences and retiring Baby Boomers are thrifty on their fixed incomes. Headlines such as "Millennials Are Killing Chains Like Buffalo Wild Wings And Applebee's" are not uncommon.

Top 5 Performing Stocks To Own For 2018: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

Top 5 Performing Stocks To Own For 2018: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Paul Ausick]

    Ziopharm Oncology Inc. (NASDAQ: ZIOP) dropped more than 10% Tuesday to post a 52-week low of $3.77 after closing at $4.20 on Monday. The 52-week high is $7.88. Volume was around 3.7 million, more than double the daily average. The company reported Tuesday on progress of two platforms it is developing and investors did not like what they heard.

  • [By Todd Campbell]

    It garnered a lot of attention in 2015 when Ziopharm (NASDAQ:ZIOP) announced it would use its “sleeping beauty” technology to improve upon chimeric antigen receptor T-cell therapies that it was developing. Then, its mosquitoes that are engineered so that they can’t reproduce and spread disease won investor interest during the Zika virus outbreak in 2015 and 2016.

  • [By Keith Speights]

    Over the last 12 months, bluebird bio (NASDAQ:BLUE) stock has more than doubled. During the same period, Ziopharm Oncology’s (NASDAQ:ZIOP) share price has tumbled over 30%. That’s the past, though. Which of these two clinical-stage biotech stocks is the better pick for investors now?

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ziopharm Oncology (ZIOP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) fell 42 percent to $2.25 in pre-market trading after dropping 31.45 percent on Thursday. Stellar Biotechnologies priced 2.075 million units at price of $2.65 per unit.
    Symantec Corporation (NASDAQ: SYMC) shares fell 25.2 percent to $21.82 in pre-market trading. Symantec reported better-than-expected earnings for its fourth quarter, but issued weak second-quarter guidance.
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares fell 9.5 percent to $10 in pre-market trading after surging 7.79 percent on Thursday.
    ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) fell 8.9 percent to $4.11 in pre-market trading after the company posted wider-than-expected Q1 loss.
    Redfin Corporation (NASDAQ: RDFN) fell 8.6 percent to $21.00 in pre-market trading after reporting Q1 results.
    Geron Corporation (NASDAQ: GERN) fell 8.3 percent to $3.33 in pre-market trading. Geron posted a Q1 loss of $0.04 per share.
    Talend S.A. (NASDAQ: TLND) shares fell 6 percent to $56 in pre-market trading after reporting Q1 results.
    Flotek Industries, Inc. (NYSE: FTK) fell 5.4 percent to $3.54 in pre-market trading after dropping 2.35 percent on Thursday.
    Halozyme Therapeutics, Inc. (NASDAQ: HALO) fell 5.1 percent to $18.95 in pre-market trading after reporting Q1 results.
    Yelp Inc. (NYSE: YELP) shares fell 4.9 percent to $45.40 in pre-market trading. Yelp reported stronger-than-expected results for its first quarter on Thursday.
    Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares fell 3.3 percent to $7.50 in pre-market trading after dropping 4.32 percent on Thursday

Top 5 Performing Stocks To Own For 2018: NF Energy Saving Corporation(NFEC)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top 5 Performing Stocks To Own For 2018: China Petroleum & Chemical Corporation(SNP)

Advisors’ Opinion:

  • [By Max Byerly]

    News headlines about Sinopec (NYSE:SNP) have been trending somewhat positive on Saturday, Accern reports. Accern identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Sinopec earned a coverage optimism score of 0.23 on Accern’s scale. Accern also gave headlines about the oil and gas company an impact score of 45.9265677546286 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Joseph Griffin]

    Sinopec (NYSE:SNP) announced a Semi-Annual dividend on Wednesday, March 28th, Zacks reports. Investors of record on Friday, May 25th will be paid a dividend of 4.568 per share by the oil and gas company on Thursday, June 21st. The ex-dividend date is Thursday, May 24th.

fixed income investments

Can the Trump Stock Rally Last?

Bob Rodriguez: Trump Might Be Acting; Huge Financial Crisis Still Looming

Why Former Reagan Official Stockman Sees a Huge Trump Correction

As investors pile into index-based funds to chase lower fees, one fund research group is sharing its view on what that choice means for investors over time, and the results should surprise both advisors and their clients.

In the longer term, Dalbar says, active investments have produced better results, which reflects investors’ tendency to stay in these funds for longer periods of time.

It also highlights the relative “closeness” of the different performance results of active and passive funds, which suggests that investors and advisors should look beyond investment characteristics and “always include situational factors applicable” to individual investors. 

The following 12 features should be considered (along with costs) when picking active and passive funds, according to Dalbar:

fixed income investments: Oceaneering International, Inc.(OII)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Oceaneering International (NYSE:OII) warned investors earlier this year that 2018 would be a challenging one. The offshore service and product company also thought that the first quarter would be particularly tough because it’s a seasonally weaker quarter. While itdidn’t go exactly as the company envisioned, the results met its muted expectations overall.

  • [By Ethan Ryder]

    Oceaneering International (NYSE:OII) was the recipient of some unusual options trading activity on Monday. Stock traders purchased 833 put options on the stock. This is an increase of approximately 1,415% compared to the average daily volume of 55 put options.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Oceaneering International (OII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Cypress Energy Partners (NYSE: CELP) and Oceaneering International (NYSE:OII) are both oils/energy companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, institutional ownership, earnings and profitability.

fixed income investments: FibroGen, Inc(FGEN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    FibroGen (NASDAQ:FGEN) Director Jorma Routti sold 6,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The shares were sold at an average price of $47.10, for a total transaction of $282,600.00. Following the completion of the transaction, the director now directly owns 133,840 shares in the company, valued at approximately $6,303,864. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

fixed income investments: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Todd Campbell]

    It garnered a lot of attention in 2015 when Ziopharm (NASDAQ:ZIOP) announced it would use its “sleeping beauty” technology to improve upon chimeric antigen receptor T-cell therapies that it was developing. Then, its mosquitoes that are engineered so that they can’t reproduce and spread disease won investor interest during the Zika virus outbreak in 2015 and 2016.

  • [By Paul Ausick]

    Ziopharm Oncology Inc. (NASDAQ: ZIOP) dropped more than 10% Tuesday to post a 52-week low of $3.77 after closing at $4.20 on Monday. The 52-week high is $7.88. Volume was around 3.7 million, more than double the daily average. The company reported Tuesday on progress of two platforms it is developing and investors did not like what they heard.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) fell 42 percent to $2.25 in pre-market trading after dropping 31.45 percent on Thursday. Stellar Biotechnologies priced 2.075 million units at price of $2.65 per unit.
    Symantec Corporation (NASDAQ: SYMC) shares fell 25.2 percent to $21.82 in pre-market trading. Symantec reported better-than-expected earnings for its fourth quarter, but issued weak second-quarter guidance.
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares fell 9.5 percent to $10 in pre-market trading after surging 7.79 percent on Thursday.
    ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) fell 8.9 percent to $4.11 in pre-market trading after the company posted wider-than-expected Q1 loss.
    Redfin Corporation (NASDAQ: RDFN) fell 8.6 percent to $21.00 in pre-market trading after reporting Q1 results.
    Geron Corporation (NASDAQ: GERN) fell 8.3 percent to $3.33 in pre-market trading. Geron posted a Q1 loss of $0.04 per share.
    Talend S.A. (NASDAQ: TLND) shares fell 6 percent to $56 in pre-market trading after reporting Q1 results.
    Flotek Industries, Inc. (NYSE: FTK) fell 5.4 percent to $3.54 in pre-market trading after dropping 2.35 percent on Thursday.
    Halozyme Therapeutics, Inc. (NASDAQ: HALO) fell 5.1 percent to $18.95 in pre-market trading after reporting Q1 results.
    Yelp Inc. (NYSE: YELP) shares fell 4.9 percent to $45.40 in pre-market trading. Yelp reported stronger-than-expected results for its first quarter on Thursday.
    Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares fell 3.3 percent to $7.50 in pre-market trading after dropping 4.32 percent on Thursday

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ziopharm Oncology (ZIOP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights]

    Over the last 12 months, bluebird bio (NASDAQ:BLUE) stock has more than doubled. During the same period, Ziopharm Oncology’s (NASDAQ:ZIOP) share price has tumbled over 30%. That’s the past, though. Which of these two clinical-stage biotech stocks is the better pick for investors now?

fixed income investments: Empire State Realty Trust, Inc.(ESRT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Prudential Financial Inc. cut its stake in Empire State Realty (NYSE:ESRT) by 0.5% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,745,889 shares of the real estate investment trust’s stock after selling 8,046 shares during the quarter. Prudential Financial Inc.’s holdings in Empire State Realty were worth $29,313,000 at the end of the most recent quarter.

  • [By ]

    Empire State Realty Trust (ESRT) : “The yield on this one is too low.”

    DowDuPont (DWDP) : “I’m not running away, I’m sticking with them.”

  • [By ]

    For example, nobody is going to come along and build another Empire State Building. In fact, you can actually invest in this building through the Empire State Realty Trust (NYSE: ESRT).

fixed income investments: EP Energy Corporation(EPE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday morning, the energy shares rose 0.76 percent. Meanwhile, top gainers in the sector included Seadrill Limited (NYSE: SDRL), up 59 percent, and EP Energy Corporation (NYSE: EPE) up 7 percent.

  • [By Lisa Levin] Gainers
    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares jumped 31.6 percent to $12.18 following TripAdvisor Q1 earnings beat.
    ZAGG Inc (NASDAQ: ZAGG) rose 26.5 percent to $14.55 after the company posted better-than-expected Q1 earnings.
    OPKO Health, Inc. (NASDAQ: OPK) shares gained 25 percent to $4.0234 following Q1 beat.
    Axon Enterprise, Inc. (NASDAQ: AAXN) jumped 23.5 percent to $55.12 following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Penn Virginia Corporation (NASDAQ: PVAC) gained 23.3 percent to $59.00 after reporting Q1 results.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 22.5 percent to $47.51 after the company reported stronger-than-expected results for its first quarter on Tuesday.
    Sears Holdings Corporation (NASDAQ: SHLD) shares surged 21.7 percent to $3.36. Amazon.com's partnership with Sears started in 2017 with an agreement to sell Kenmore-branded appliances online. On Wednesday, the companies announced an extension of their relationship to now include tire delivery and installations.
    EP Energy Corporation (NYSE: EPE) jumped 21.3 percent to $2.68 following Q1 results.
    LendingClub Corporation (NYSE: LC) surged 20.4 percent to $3.395 following better-than-expected Q1 earnings.
    Superior Industries International, Inc. (NYSE: SUP) gained 19 percent to $15.82 after reporting Q1 results.
    Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares rose 18.5 percent to $8.13 following Q1 results.
    Twilio Inc. (NYSE: TWLO) rose 18.3 percent to $52.47 after the company posted strong quarterly results.
    Cerus Corporation (NASDAQ: CERS) shares jumped 18.3 percent to $6.47 following quarterly results.
    IEC Electronics Corp. (NYSE: IEC) shares climbed 17 percent to $4.68 after reporting better-than-expected quarterly earnings.
    New Relic, Inc. (NYSE: NEWR) rose 16.8 percent to $90.10 following Q4 results.
    Gulfport Energy Corporation (NASDAQ: GPOR)
  • [By Lisa Levin]

    Wednesday afternoon, the energy shares climbed 1.59 percent. Meanwhile, top gainers in the sector included SeaDrill Limited (NYSE: SDRL), up 77 percent, and EP Energy Corporation (NYSE: EPE), up 19 percent.

  • [By Lisa Levin] Gainers
    athenahealth, Inc. (NASDAQ: ATHN) shares climbed 23.2 percent to $155.19 after Elliott Management confirmed a $160 per share cash offer for athenahealth.
    Evolus, Inc. (NASDAQ: EOLS) gained 21.3 percent to $8.83. Evolus named David Moatazedi as new CEO.
    VivoPower International PLC (NASDAQ: VVPR) climbed 18.2 percent to $3.12 after falling 39.86 percent on Friday.
    Gramercy Property Trust (NYSE: GPT) rose 15.6 percent to $27.53 after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.
    EP Energy Corporation (NYSE: EPE) rose 13 percent to $2.26.
    Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) gained 11.9 percent to $7.35.
    National CineMedia, Inc. (NASDAQ: NCMI) surged 11.8 percent to $6.24 after the company posted upbeat quarterly profit.
    Sanchez Energy Corporation (NYSE: SN) shares gained 11.3 percent to $3.56.
    CVR Refining, LP (NYSE: CVRR) shares rose 8.8 percent to $18.875.
    Monaker Group, Inc. (NASDAQ: MKGI) rose 8.7 percent to $2.9683.
    Kosmos Energy Ltd. (NYSE: KOS) shares rose 7.4 percent to $7.40.
    Ceragon Networks Ltd. (NASDAQ: CRNT) rose 7 percent to $2.88 after climbing 1.89 percent on Friday.
    Cloudera, Inc. (NYSE: CLDR) surged 6 percent to $15.93. Craig-Hallum initiated coverage on Cloudera with a Buy rating.
    Illumina, Inc. (NASDAQ: ILMN) rose 5.1 percent to $257.35. Barclays upgraded Illumina from Equal-Weight to Overweight.

    Check out these big penny stock gainers and losers

  • [By Lisa Levin]

    On Wednesday, the energy shares climbed 1.48 percent. Meanwhile, top gainers in the sector included SeaDrill Limited (NYSE: SDRL), up 15 percent, and EP Energy Corporation (NYSE: EPE), up 15 percent.

fixed income investments: Nemaska Lithium Inc. (NMKEF)

Advisors’ Opinion:

  • [By ]

    Over the past two months, Nemaska Lithium (OTCQX:NMKEF) has steadily been updating the market on its half-billion-dollar-plus financial raise. The company has aggressively set targets to build out a vertically integrated lithium mining and processing operation ideally positioned to meet growing demand in North America and Europe.

  • [By ]

    Canadian hard-rock lithium chemicals company Nemaska Lithium (OTCQX:NMKEF) is presently at the end of completing a $500 million capital raise which will allow the company to expand into Phase 2 production of the its facility in Quebec. The company has closed an equity deal valued at nearly $100 million from Japans SoftBank (OTCPK:SFTBY), executed a streaming agreement with Orion Mine Finance LF valued at over $150 million, and engaged with such high-quality financial groups including Clarkson Platou Securities and Pareto Securities as managers of the bond issuance. Further, Nemaska has signed multiple offtake agreements, including NorthVolt, FMC, Softbank and Johnson Matthey Battery Materials, for the purchase of its lithium chemicals once production begins.

Top Stocks To Watch For 2018

Large cap upscale accessories retailer Coach Inc (NYSE: COH) reported FY17 Q4 and year end earnings before the market opened on Tuesday with shares falling off in premarket trading despite profit doubling. Q4 net sales totaled $1.13 billion versus $1.15 billion in the prior year. Excluding the additional week included in fiscal 2016 results, net sales increased 6% on a reported basis and 7% on a constant currency basis. The earnings release noted that as planned, the Companys strategic decision to elevate the Coach brands positioning in the North American wholesale channel through a reduction in promotional events and door closures negatively impacted sales growth by approximately 60 basis points in the quarter. Net income was $152 million versus net income of $82 million.

For fiscal year 2017, net sales totaled $4.49 billion versus $4.49 billion in the prior year. Excluding the additional week included in fiscal 2016 results, net sales increased 2% on both a reported and constant currency basis. Net income totaled $591 million on a reported basis versus reported net income of $461 million.

Top Stocks To Watch For 2018: Citrix Systems Inc.(CTXS)

Advisors’ Opinion:

  • [By Jim Robertson]

    At the beginning of the month, LogMeIn announced the completion of its merger with Citrix Systems, Inc (NASDAQ: CTXS) GetGo, Inc subsidiary.

    In late October, LogMeIn reported 22% third quarter revenue growth to $85.1 million and GAAP net loss was $0.7 million compared to a GAAP net income of $5.6 million. LogMeIn will report its fourth quarter and fiscal year 2016 financial results for the period ended December 31, 2016 following the close of market on February 28.

  • [By Ben Levisohn]

    Wynn Resortsgained 4.8% to $104.30 today, while the S&P 500 finished little changed at2,373.47. At 2:45, Wynn was easily the top performing stock in the S&P 500, only to be surpassed by Citrix’s (CTXS) late day surge.

  • [By Ben Levisohn]

    Citrix Systems (CTXS)soared nearly to the top of the S&P 500 today afterreports it had hired Goldman Sachs (GS) to pursue a sale of the company.

    S. MARTIN/AFP/Getty Images

    Citrix Systemsgained 6.8% to $84.93 today, while the S&P 500 finished little changed at 2,373.47.

    Business Insider’s Matt Weinbergerhas the details:

    Citrix, the $13 billion tech company best known for software like GoToMeeting, is working with Goldman Sachs to negotiate a possible sale, reports Bloomberg, citing anonymous sources.

    This isn’t the first time that Citrix has shopped itself around: in late 2015, and under pressure from activist shareholder Elliott Management, Citrix was said to have unsuccessfully tried to find a buyer.

    Citrix Systems market cap rose t0 $13.3 billion today from $12.4 billion on Friday. It reported net income of $536 million on sales of $3.4 billion in 2016.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Citrix Systems, Inc. (NASDAQ: CTXS) which jumped 6.8% to $84.93. The stocks 52-week range is $59.72 to $87.99. Volume was 5.19 million which is well above the daily average of around 2.09 million shares.

Top Stocks To Watch For 2018: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):

    Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.

  • [By Lisa Levin]

    Shares of Spark Therapeutics Inc (NASDAQ: ONCE) were down 36 percent to $47.08 on preliminary SPK-8011 trial data.

    Athenex Inc (NASDAQ: ATNX) was down, falling around 13 percent to $13.95. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.

  • [By Chris Lange]

    Spark Therapeutics Inc. (NASDAQ: ONCE) saw its shares take a big step back on Monday after the firm reported less than favorable results at the American Society of Hematology (ASH) annual meeting. Analysts have taken this opportunity to weigh in on the stock:

  • [By Paul Ausick]

    Spark Therapeutics Inc. (NASDAQ: ONCE) dropped 44% Monday to post a new 52-week low of $41.06 after closing at $73.38 on Friday. The 52-week high is $91.75. Volume was around 13.5 million, nearly 30 times the daily average of about 480,000. The company’s hemophilia A drug posted disappointing trial results.

Top Stocks To Watch For 2018: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Four ideas turned up in this screen that might be of interest (prices as of February 9th close):

    Heron Therapeutics (NASDAQ:HRTX) by ONeil Trader – published February 3rd, 2017, $525M Market cap, down ~2% since publication, author’s price target offers 130% upside. HRTX isn’t a generic drug provider, but its CINV franchise vs. the growth of a new drug gives it a similar sort of profile, and arguably a favorable risk/reward; commenters were mostly positive on the thesis. VistaGen Therapeutics (OTC:VTGN) by Logical Assessment – published July 29, 2016, $24M market cap, down 16% since publication, author’s price target offers 100%+ upside. This is obviously deeper into the speculative pile, but if the author’s thesis holds about VistaGen’s unique angle in the antidepressant drug space, comparable deals suggest good upside. (Of course, it’s always dangerous to rely solely on comparables). Dr. Reddy’s Laboratories (NYSE:RDY) by Buddy Lyons – published July 5, 2016, $7.6B market cap, down ~13% since publication, author’s price target offers just shy of 100% upside. Dr. Reddy’s is a more obvious comparable to TEVA, with a generics business but also a manufacturing business and a proprietary products branch. The company bought a divestiture package of drugs from TEVA as part of the Allergan/Actavis deal. A big overhang was an FDA warning letter; the FDA is due to reinspect facilities this month or next, which could resolve that one way or another. Lannett (NYSEMKT:LCI) by Lateral Capital Management – published May 27, 2016, $750M market cap, down ~9% since publication, author’s price target offers 75% upside. LCI’s trading had been 90% correlated with Valeant, but Lateral Capital Management argues that the correlation is unjustified. The article does a deep dive into the company’s valuation and credit risk, and was well received at the time, even if the market hasn’t agreed…yet.

    I also checked to see if there are any ideas starting to play out on the short si

  • [By Money Morning News Team]

    Consider one of the top penny stocks from December,VistaGen Therapeutics Inc.(Nasdaq: VTGN). VTGN shares soared 156% in a single day of trading on Dec. 6.

  • [By William Romov]

    VistaGen Therapeutics Inc. (Nasdaq: VTGN) is among the top penny stocks to watch this week after climbing 135% in just three trading sessions last week.

  • [By Money Morning News Team]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up from $0.92 to $2.55 on Dec. 6. Since then, the stock pulled back to $1.02. Investors who bought at $2.55 are sitting on a 60% loss today (Dec. 18).

  • [By Money Morning Staff Reports]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up from $0.92 to $2.55 on Dec. 6. Since then, the stock pulled back to $1.07. Investors who bought at $2.55 are sitting on a 58% loss today (Jan. 8).

Top Stocks To Watch For 2018: iShares PHLX SOX Semiconductor Sector Index Fund(SOXX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group peaking in early 2015 while peerSTMicroelectronics NV (NYSE: STM) hasnt performed much better and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX) have performed better:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group giving investors and traders a bit of a roller-coaster ride while peerSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX) really took off last year:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group along with peersSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX)all taking offlast year albeit MRVL has underperformed ETF benchmarks:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group in an uptrend for the past two year, but also under performingpeerSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX):

Top Stocks To Watch For 2018: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.88 percent. Meanwhile, top losers in the sector included Simulations Plus, Inc. (NASDAQ: SLP), down 7 percent, and ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), down 7 percent.

  • [By Paul Ausick]

    Ziopharm Oncology Inc. (NASDAQ: ZIOP) dropped more than 10% Tuesday to post a 52-week low of $3.77 after closing at $4.20 on Monday. The 52-week high is $7.88. Volume was around 3.7 million, more than double the daily average. The company reported Tuesday on progress of two platforms it is developing and investors did not like what they heard.

Top Stocks To Watch For 2018: Winnebago Industries Inc.(WGO)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Supply could come from any number of industry players, including Winnebago Industries, Inc. (NYSE: WGO), Thor Industries, Inc. (NYSE: THO), Polaris Industries Inc. (NYSE: PII) and Camping World Holdings Inc (NYSE: CWH). However, whether it comes from existing inventory and whether suppliers can meet the demand are yet to be seen.

  • [By Dan Caplinger]

    Friday was a good day on Wall Street, as the stock market responded favorably to encouraging news on the employment front. The U.S. unemployment rate dropped on fairly strong job creation during the month of February, and that helped push the Dow, S&P 500, and Nasdaq Composite to modest gains of roughly between a quarter percent and a half percent. Yet even with a positive mood among market participants, some stocks weren’t able to participate in the end-of-week rally. Finisar (NASDAQ:FNSR), Zumiez (NASDAQ:ZUMZ), and Winnebago Industries (NYSE:WGO) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Peter Graham]

    The Q2 2017 earnings report for small cap motor home or RV stock Winnebago Industries, Inc (NYSE: WGO) is scheduled for before the market opens onWednesday (March 22nd). Back in2014, Winnebago Industries was in our SmallCap Network Elite Opportunity (SCN EO) portfolioas we believed the company would benefit from lower gas pricesalong with aBaby Boomer generation whos recreational retirement spending will increase. OurSCN EO newsletter noting at the time:

Top 10 Clean Energy Stocks To Own For 2018

Some investors are ready to write the obituary for the market phenomenon known as risk on, risk off. Long-suffering stock pickers might be tempted to do some grave dancing.

Risk on, risk off, known by the unfortunate acronym, RORO, was a dominant feature of financial markets in the aftermath of the 2008-2009 crisis. It meant that assets perceived as risky, such as stocks, commodities, and nongovernment bonds, tended to either rally or sell off in lockstep. Assets perceived as safe tended to do the same, but in the opposite direction.

Top 10 Clean Energy Stocks To Own For 2018: First Commonwealth Financial Corporation(FCF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The last year Netflix generated positive free cash flow (FCF), was 2010, which happens to coincide with the year it began significantly increasing its content library, per Figure 2 above. Since then, Netflix has burned through cumulative $3.6 billion in cash, per Figure 3, and the cash burn is only accelerating. In 2015, NFLX’s FCF sat at -$1.6 billion, and over the last twelve months, FCF has worsened to -$1.9 billion.

Top 10 Clean Energy Stocks To Own For 2018: Renewable Energy Group, Inc.(REGI)

Advisors’ Opinion:

  • [By Manikandan Raman]

    There also some lesser known clean energy stocks that may witness downward movement on potential Trump win on negative sentiment. They include Pattern Energy Group Inc (NASDAQ: PEGI), Enviva Partners LP (NYSE: EVA), TerraForm Global Inc (NASDAQ: GLBL), Renewable Energy Group Inc (NASDAQ: REGI) and Ameresco Inc (NYSE: AMRC).

Top 10 Clean Energy Stocks To Own For 2018: Scorpio Tankers Inc.(STNG)

Advisors’ Opinion:

  • [By William Romov]

    Pyxis is a Greece-based liquid fuel transporter operating a fleet of six double-hull tankers in the United States. There was no recent news from the company or analyst revisions that sparked the stocks surge. But some analysts suspect the recent $90 million share offering from Scorpio Tankers Inc. (NYSE: STNG) attracted unusually high speculation in the sector.

  • [By Paul Ausick]

    Scorpio Tankers Inc. (NYSE: STNG) dropped 4.9% Wednesday to post a new 52-week low of $3.10 after closing at $3.26 on Tuesday. The stock’s 52-week high is $4.93. Volume of around 13 million was nearly four times the daily average. The company announced this morning that it had priced an underwritten offering of 30 million shares at $3.00 a share.

  • [By Paul Ausick]

    Scorpio Tankers Inc. (NYSE: STNG) dropped 1 cent Monday to post a new 52-week low of $3.06 after closing at $3.07 on Friday. The stock’s 52-week high is $4.93. Volume of around 4.2 million about 5% above the daily average. The shipping firm priced a secondary offering of 30 million shares at $3.00 a share late last week.

Top 10 Clean Energy Stocks To Own For 2018: Avanir Pharmaceuticals Inc(AVNR)

Advisors’ Opinion:

  • [By Paul Ausick]

    Stocks on the move: Galena Biopharma Inc. (NASDAQ: GALE) is down 15.4% at $1.93 after pricing a secondary offering of 17.5 million units at $2.00. Safeway Inc. (NYSE: SWY) is up 6.1% at $28.21, after an analysts upgrade which sent shares to a new 52-week high of $28.88 earlier. Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) is down 18.2% at $4.08.

Top 10 Clean Energy Stocks To Own For 2018: Genomic Health, Inc.(GHDX)

Advisors’ Opinion:

  • [By Brian Orelli]

    Genomic Health (NASDAQ:GHDX) closed up 10.2% Tuesday following its announcement of solid fourth-quarter earnings after the bell Monday. The company’s 2017 guidance certainly didn’t hurt investors’ confidence either.

  • [By Brian Orelli]

    Genomic Health (NASDAQ:GHDX) swung to a profit in the fourth quarter on the back of solid revenue growth and expects to have another productive year in 2017 as the company continues to increase reimbursement for its genetic tests.

Top 10 Clean Energy Stocks To Own For 2018: MEDIFAST INC(MED)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Carrizo Oil and Gas Inc. (NASDAQ: CRZO), Medifast Inc. (NYSE: MED), Medley Capital Corp. (NYSE: MCC), Occidental Petroleum Corp. (NYSE: OXY) and Sothebys (NYSE: BID).

  • [By Lisa Levin]

    In trading on Friday, non-cyclical consumer goods & services shares rose by just 0.3 percent. Meanwhile, top losers in the sector included Medifast Inc (NYSE: MED), down 5 percent, and Bridgford Foods Corporation (NASDAQ: BRID), down 6 percent.

  • [By Peter Graham]

    A long term performance chart shows small cap weight loss or dieting stocks Weight Watchers International and Reliv International, Inc (NASDAQ: RELV) still underperforming whileNutriSystem Inc (NASDAQ: NTRI) and Medifast Inc (NYSE: MED) began taking off early last year:

  • [By Peter Graham]

    Although obesity is widespread, small cap dieting stocks havetended to causeinvestor portfolios to loose weight. A long term performance chart shows small cap weight loss or dieting stocks Weight Watchers International and Reliv International, Inc (NASDAQ: RELV) stillbelow or at breakeven for longer term investors whileMedifast Inc (NYSE: MED)has performed better and NutriSystem Inc (NASDAQ: NTRI) hasfinally begun to take offearly last year:

Top 10 Clean Energy Stocks To Own For 2018: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.88 percent. Meanwhile, top losers in the sector included Simulations Plus, Inc. (NASDAQ: SLP), down 7 percent, and ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), down 7 percent.

  • [By Paul Ausick]

    Ziopharm Oncology Inc. (NASDAQ: ZIOP) dropped more than 10% Tuesday to post a 52-week low of $3.77 after closing at $4.20 on Monday. The 52-week high is $7.88. Volume was around 3.7 million, more than double the daily average. The company reported Tuesday on progress of two platforms it is developing and investors did not like what they heard.

Top 10 Clean Energy Stocks To Own For 2018: Sorrento Therapeutics, Inc.(SRNE)

Advisors’ Opinion:

  • [By William Romov]

    San Diego-based Sorrento Therapeutics Inc. (Nasdaq: SRNE) develops drugs to treat certain types of cancer and chronic cancer pain.

    On Jan. 6, company officials will present a new proprietary technology for the treatment of cancer. Analysts are calling this new technology a potential “game-changer.”

Top 10 Clean Energy Stocks To Own For 2018: Plantronics Inc.(PLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Plantronics Inc (NYSE: PLT) were down 25 percent to $33.36. Plantronics reported better-than-expected third-quarter earnings, but the company’s revenue missed analysts’ expectations. The company announced a new 1 million share buyback plan and issued a weak earnings forecast for the fourth quarter.

Top 10 Clean Energy Stocks To Own For 2018: Archrock, Inc.(AROC)

Advisors’ Opinion:

  • [By Dustin Parrett]

    Company Name

    Share PriceYTDMarket CapClayton Williams Energy Inc. (NYSE: CWEI)$138.8216.4%2.4BDiamondback Energy Inc. (Nasdaq: FANG)$106.365.42%$9.38BWestern Gas Partners LP (NYSE: WES)$65.6411.71%$9.67BTesoro Logistics LP (NYSE: TLLP)$59.3416.79%$6.25BResolute Energy Corp. (NYSE: REN)$46.0811.87%$931.13MAntero Midstream Partners LP (NYSE: AM)$34.9813.28%$6.4BExterran Corp. (NYSE: EXTN)$33.9942.22%$1.19BDominion Midstream Partners LP (NYSE: DM)$32.9011.34%$2.6BNextEra Energy Partners LP (NYSE: NEP)$31.1922.12%$1.68BArchrock Inc. (NYSE: AROC)$16.0021.21%$1.12B

    While some of these stocks have performed well, we arent recommending this list of natural gas stocks. Thats because we arent interested in stocks that have already peaked at Money Morning; were interested in the next big winner. And we have one that could surge in 2017

Top Casino Stocks To Buy For 2018

Late last year, Japan legalized casinos in the country, opening up a gaming industry that could generate as much as $30 billion a year in revenues and become the second-largest casino market in the world. As several players scout for licenses, Las Vegas Sands (NYSE: LVS) is ready to invest heavily in the region, committing to an initial investment of $10 billion. While this is a significant number, if Las Vegas Sands is able to capture a decent share in the market, it would make sense given the revenue potential of the market. Currently, Macau and Singapore are the largest value drivers of the company, together accounting for more than 80% of its valuation.

The company is heavily dependent on Macau for revenues, and regulation changes in the region have impacted it negatively. At its peak in 2013, Macau’s gaming market had reached a size of $45 billion. However, after stricter regulations imposed by Chinese regulators, revenues started slumping. In 2016, the total amount won by casinos in the region stood at nearly $28 billion. Japan is likely to emerge as a huge market for casinos, with annual revenue estimates ranging from $10 billion to $30 billion.

Top Casino Stocks To Buy For 2018: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.88 percent. Meanwhile, top losers in the sector included Simulations Plus, Inc. (NASDAQ: SLP), down 7 percent, and ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), down 7 percent.

Top Casino Stocks To Buy For 2018: Genesis Energy, L.P.(GEL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Lennar Corporation (NYSE: LEN) reported better-than-expected profit for its first quarter on Tuesday.
    General Mills, Inc. (NYSE: GIS) reported upbeat earnings for its fiscal third quarter, while sales missed estimates.
    Genesis Energy, L.P. (NYSE: GEL) disclosed that it has priced its public offering of 4 million common units for gross proceeds of $124 million.
    South State Corporation (NASDAQ: SSB) reported that it has increased its buyback plan from 250,000 shares to 1 million shares.

Top Casino Stocks To Buy For 2018: Aurora Cannabis Inc. (ACBFF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Also quite recently, Benzinga asked Alan Brochstein, founding partner at New Cannabis Ventures and founder at 420 Investor, about plays in the marijuana industry against such an uncertain backdrop. The expert mentioned a few Canadian Licensed Producers, including AURORA CANNABIS IN COM NPV (OTC: ACBFF), APHRIA INC NPV (OTC: APHQF), METTRUM HEALTH COR COM NPV (OTC: MQTRF), ORGANIGRAM HLDGS I COM NPV (OTC: OGRMF), SUPREME PHARMACEUT COM NPV (OTC: SPRWF) and CANOPY GROWTH CORP COM NPV (OTC: TWMJF), as well as “the only” biotech stock in the space, GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH).

  • [By SEEKINGALPHA.COM]

    This article is for those who are hopeful of the long-term view and want to get in ahead of time. This article will compare the three front-runners of the Canadian cannabis industry, Canopy Growth Corp. (OTCPK:TWMJF), Aphria (NYSE:APH), and Aurora (OTCQX:ACBFF). Although these companies will soon have to prove themselves in a new environment, there is plenty to study right now. We will be comparing revenue growth, production capacity, valuations, and then making financial projections. The result will be a recommendation of Aurora followed by Canopy. Again this article is meant to compare competitors. The industry has the potential to be a 22.6B industry but the thesis for investing in Canadian cannabis is a separate topic and I encourage you to consider the risks.

  • [By Javier Hasse]

    While biotechs like GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) and Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) only lost 0.45 percent and 0.36 percent respectively, other companies experienced a large tumble. CANOPY GROWTH CORP COM NPV (OTC: TWMJF) lost 4.71 percent, AURORA CANNABIS IN COM NPV (OTC: ACBFF) slipped 2.93 percent, APHRIA INC COM NPV (OTC: APHQF) dropped 1.01 percent, and MassRoots Inc (OTC: MSRT) plummeted an astounding 9.00 percent.

  • [By Sean Williams]

    This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.

    GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%

    As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!

  • [By SEEKINGALPHA.COM]

    Todays North Channel Investment article will look at Aurora Cannabis Inc. (OTCQX:ACBFF), and why they could be very appealing to any investor looking for a stock that has great potential for long-term growth.

Top Casino Stocks To Buy For 2018: Tutor Perini Corporation(TPC)

Advisors’ Opinion:

  • [By Casey Wilson]

    Take general contracting company Tutor Perini (NYSE: TPC), for example.

    The California-based contracting giant is responsible for funding many infrastructure projects, including “Big Bertha,” a huge tunnel-boring project in Seattle, Wash. This tunnel will be 9,270 feet long and 115 feet deep – allowing for a major highway to be carried under downtown Seattle.

Top Casino Stocks To Buy For 2018: Diplomat Pharmacy, Inc.(DPLO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Diplomat Pharmacy Inc (NYSE: DPLO) were down 23 percent to $14.71. Diplomat Pharmacy agreed to buy LDI Integrated Pharmacy Services. Baird downgraded Diplomat Pharmacy from Outperform to Neutral.

  • [By Paul Ausick]

    Diplomat Pharmacy Inc. (NYSE: DPLO) dropped 7.4% Monday, posting a new 52-week low of $12.25 after closing at $13.23 on Friday. The stock’s 52-week high is $38.94. The specialty pharmacy company said this morning that revenues and adjusted EBITDA for 2016 will come in at or near the low end of the company’s previously announced range.

Top Casino Stocks To Buy For 2018: Vaalco Energy Inc(EGY)

Advisors’ Opinion:

  • [By Monica Gerson]

    VAALCO Energy, Inc. (NYSE: EGY) is expected to post a quarterly loss at $0.11 per share on revenue of $18.59 million.

    B2Gold Corp (NYSE: BTG) is estimated to post its quarterly earnings at $0.00 per share on revenue of $135.84 million.